The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with pancreatic adenocarcinoma (PDAC).
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; Astellas Pharma; AstraZeneca; Bayer; Biocartis; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; GlaxoSmithKline; Halozyme; Incyte; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Rikke Løvendahl Eefsen
Consulting or Advisory Role - Amgen
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; BMS; Ipsen; Merck Serono; MSD
Consulting or Advisory Role - Bayer; BMS; Janssen-Cilag; Merck Serono; MSD
Research Funding - BMS
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - BMS; Merck Serono
 
Zanete Zvirbule
No Relationships to Disclose
 
Audrius Ivanauskas
No Relationships to Disclose
 
Dirk Arnold
Employment - Asklepios Kliniken
Honoraria - Amgen; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Ipsen; Merck Serono; Merck Sharp and Dome; Pierre Fabre; Roche/Genentech; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Terumo
Research Funding - Oncolytics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Boston Scientific
(OPTIONAL) Uncompensated Relationships - ESMO; ESMO Open; European Organisation for Research and Treatment of Cancer (EORTC); German Cancer Society; German Society for Hematology and Medical Oncology
 
Edita Baltruskeviciene
No Relationships to Disclose
 
Per Pfeiffer
No Relationships to Disclose
 
Jeffrey Yachnin
No Relationships to Disclose
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications; Advanz Pharma; Amgen; AstraZeneca (I); Bayer; BMS; Boehringer Ingelheim (I); Gilead Sciences (I); Hutchmed; Ipsen; Lilly (I); Merck; Midatech Pharma; Mirati Therapeutics (I); MSD; Novartis; Pfizer (I); PharmaMar; Roche (I); Sanofi (I); Servier; Takeda (I)
Consulting or Advisory Role - HMP
Research Funding - BMS (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck; MSD; Roche
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Christiane Jungels
Travel, Accommodations, Expenses - Ipsen; PharmaMar
 
Laurids Poulsen
No Relationships to Disclose
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
 
Ignacio Garcia-Ribas
Employment - Cantargia AB
Stock and Other Ownership Interests - Cantargia AB; Sanofi
Consulting or Advisory Role - Shionogi; TFS; Triact Therapeutics
 
Nedjad Losic
Employment - Cantargia AB
 
Joelle Collignon
Consulting or Advisory Role - Bayer (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Pfizer (Inst); Roche (Inst)